Total global biologics spending from 2002 and 2017 (Figures expressed in billions of U.S. dollars, unless otherwise specified)
The data displays total global spending on biologics in 2002, 2007 and 2012, with a projection for 2017. In 2002, expenditure on biosimilars was 46 billion USD.